Does Rallies show 13F holders for ZLAB?

Yes. Rallies tracks hedge fund and 13F ownership data for ZLAB, including fund names, share counts, latest tracked quarter, and position changes when available.

Is ZLAB research on Rallies investment advice?

No. Rallies provides research, data, and educational context for ZLAB. It does not provide personalized investment advice.

ZLAB (Zai Lab Limited American Depositary Shares) Stock Analysis - Hedge Fund Holdings

Zai Lab Limited American Depositary Shares (ZLAB) is a publicly traded Healthcare sector company. As of May 21, 2026, ZLAB trades at $18.44 with a market cap of $2.12B and a P/E ratio of -108.98. ZLAB moved +2.29% today. Year to date, ZLAB is +3.98%; over the trailing twelve months it is -42.35%. Its 52-week range spans $15.96 to $44.34. Analyst consensus is strong buy with an average price target of $34.27. Rallies surfaces ZLAB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns ZLAB stock?

Hedge funds tracked by Rallies that own ZLAB include Viking Global, Orbimed Advisors, and Eisler Capital. The latest tracked quarter is Sep 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Zai Lab Limited American Depositary Shares.

ZLAB Key Metrics

Key financial metrics for ZLAB
Metric	Value
Price	$18.44
Market Cap	$2.12B
P/E Ratio	-108.98
EPS	$-0.17
Dividend Yield	0.00%
52-Week High	$44.34
52-Week Low	$15.96
Volume	151
Avg Volume	0
Revenue (TTM)	$453.28M
Net Income	$-178.12M
Gross Margin	58.00%

Top Hedge Funds Holding ZLAB

Viking Global holds 1.95M shares of ZLAB, changed -4.29% as of Sep 30, 2024.
Orbimed Advisors holds 231.00K shares of ZLAB, changed +0.00% as of Jun 30, 2025.
Eisler Capital holds 44.23K shares of ZLAB, changed +0.00% as of Mar 31, 2024.

Latest ZLAB News

Zai Lab Wins FDA Fast Track for DLL3-Targeting Zocilurtatug Pelitecan in epNECs — May 11, 2026
Zai Lab Q4 Revenue Up 17% to $127.6M, zoci Delivers 80% Brain ORR — Feb 28, 2026

Recent ZLAB Insider Trades

Edmondson Frazor Titus III sold 3.52K (~$71.01K) on May 14, 2026.
Du Ying sold 50.00K (~$1.00M) on May 14, 2026.
Du Ying sold 16.23K (~$315.58K) on May 13, 2026.

ZLAB Analyst Consensus

4 analysts cover ZLAB: 0 strong buy, 3 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $34.27.

Common questions about ZLAB

Who owns ZLAB stock?: Hedge funds tracked by Rallies that own ZLAB include Viking Global, Orbimed Advisors, and Eisler Capital. The latest tracked quarter is Sep 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Zai Lab Limited American Depositary Shares.
Does Rallies show 13F holders for ZLAB?: Yes. Rallies tracks hedge fund and 13F ownership data for ZLAB, including fund names, share counts, latest tracked quarter, and position changes when available.
Is ZLAB research on Rallies investment advice?: No. Rallies provides research, data, and educational context for ZLAB. It does not provide personalized investment advice.